期刊文献+

芪黄益肺合剂对慢性阻塞性肺疾病大鼠炎症因子的影响 被引量:4

Effect of Qihuangyifei Mixture on inflammatory in rat with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的观察芪黄益肺合剂对慢性阻塞性肺疾病(COPD)大鼠气道炎症因子及肺组织形态学的影响。方法单纯熏烟造模,造模后的60只SD雄性大鼠,随机分为正常组、COPD模型组、百灵胶囊对照组及芪黄益肺合剂低、中、高剂量组(均10只),观察各组治疗后大鼠气道病理组织形态学变化及支气管肺泡灌洗液(BALF)中白细胞介素8(IL-8)、肿瘤坏死因子a(TNF-a)水平。结果组织形态学变化:芪黄益肺合剂组较模型组减轻,BALF中IL-8、TNF-a含量较模型组明显降低(P<0.05)。结论芪黄益肺合剂对COPD大鼠气道炎症有一定抑制作用。 Objective To study the effect of Qihuangyifei Mixture (QM) on the inflammatory in rat with chronic obstructive pulmonary disease (COPD). Methods After molding sixty male SD rats were randomly divided into six groups: normal group, COPD model group , Bailing cap- sule control group and low, middle, high doses of QM groups( all n = 10) . The COPD model was establish by being exposed to simple fume The levels of interleukin 8 ( IL - 8 ) and tumor necrosis factor ( TNF - a) in bronchoalveolar lavage fluid (BALF) were measured and the pathology of the airway and lung tissue was observed affter treatment. Results The pathological changes were lessen in QM groups, and the levels of IL - 8 and TNF - a in BALF of QM groups were lower than in model group ( P 〈 0. 05 ) . Conclusion QM can reduce the levels of IL - 8 and TNF - a in BALF and has inhibitory effect on inflammation in the airway with COPD.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第5期373-375,共3页 The Chinese Journal of Clinical Pharmacology
基金 云南省卫生厅及财政厅专项基金资助项目
关键词 芪黄益肺合剂 慢性阻塞性肺疾病 炎症因子 白细胞介素8 肿瘤坏死因子A Qihuangyifei Mixture chronic obstructive pulmonary disease inflammatory interleukin 8 tumor necrosis factor
  • 相关文献

参考文献10

二级参考文献21

  • 1刘政,姚婉贞,陈燕,丁艳苓.白细胞介素-9在慢性阻塞性肺病发病中的作用[J].北京大学学报(医学版),2004,36(4):403-406. 被引量:7
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3Sherrill DL,Holberg CJ,Enright PL,et al.Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function.Am J Respir Crit Care Med,1994;149: 591~597
  • 4Mio T,Romberger DJ,Thompson AB,et al.Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells.Am J Respir Crit Care Med,1997;155:1770~1776
  • 5Richman-Eisenstat JB,Jorens PG,Hebert CA,et al.Interleukin-8:an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.Am J Physiol,1993;264:L413~L418
  • 6Thompson AB,Daughton D,Robbins RA,et al.Intraluminal airway inflammation in chronic bronchitis:characterization and correlation with clinical parameter.Am Rev Respir Dis,1989;140:1527~1537
  • 7Keatings VM,Collins PD,Scott DM,et al.Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.Am J Respir Crit Care Med,1996;153:530~534
  • 8GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 9Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 10Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.

共引文献8274

同被引文献42

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部